199 related articles for article (PubMed ID: 12685226)
1. [Molecular and cellular mechanisms of myocardial remodeling in heart failure].
Kremneva LV; Abaturova OV
Klin Med (Mosk); 2003; 81(2):4-7. PubMed ID: 12685226
[TBL] [Abstract][Full Text] [Related]
2. Myocyte apoptosis in heart failure.
van Empel VP; Bertrand AT; Hofstra L; Crijns HJ; Doevendans PA; De Windt LJ
Cardiovasc Res; 2005 Jul; 67(1):21-9. PubMed ID: 15896727
[TBL] [Abstract][Full Text] [Related]
3. Implications of myocardial matrix remodeling by adipokines in obesity-related heart failure.
Schram K; Sweeney G
Trends Cardiovasc Med; 2008 Aug; 18(6):199-205. PubMed ID: 19185809
[TBL] [Abstract][Full Text] [Related]
4. Gelsolin and cardiac myocyte apoptosis: a new target in the treatment of postinfarction remodeling.
Nishio R; Matsumori A
Circ Res; 2009 Apr; 104(7):829-31. PubMed ID: 19359605
[No Abstract] [Full Text] [Related]
5. Increased production of CXCL16 in experimental and clinical heart failure: a possible role in extracellular matrix remodeling.
Dahl CP; Husberg C; Gullestad L; Waehre A; Damås JK; Vinge LE; Finsen AV; Ueland T; Florholmen G; Aakhus S; Halvorsen B; Aukrust P; Oie E; Yndestad A; Christensen G
Circ Heart Fail; 2009 Nov; 2(6):624-32. PubMed ID: 19919988
[TBL] [Abstract][Full Text] [Related]
6. Functional disturbances due to structural remodeling in the failing human heart.
Hein S; Elsässer A; Kostin S; Zimmermann R; Schaper J
Arch Mal Coeur Vaiss; 2002 Sep; 95(9):815-20. PubMed ID: 12407797
[TBL] [Abstract][Full Text] [Related]
7. Apoptosis in heart failure represents programmed cell survival, not death, of cardiomyocytes and likelihood of reverse remodeling.
Haider N; Narula N; Narula J
J Card Fail; 2002 Dec; 8(6 Suppl):S512-7. PubMed ID: 12555167
[TBL] [Abstract][Full Text] [Related]
8. Nitric oxide and promotion of cardiac myocyte apoptosis.
Andréka P; Tran T; Webster KA; Bishopric NH
Mol Cell Biochem; 2004 Aug; 263(1-2):35-53. PubMed ID: 15524166
[TBL] [Abstract][Full Text] [Related]
9. Myocardial expression of survivin, an apoptosis inhibitor, in aging and heart failure. An experimental study in the spontaneously hypertensive rat.
Abbate A; Scarpa S; Santini D; Palleiro J; Vasaturo F; Miller J; Morales C; Vetrovec GW; Baldi A
Int J Cardiol; 2006 Aug; 111(3):371-6. PubMed ID: 16257070
[TBL] [Abstract][Full Text] [Related]
10. Cardiac remodeling and failure: from molecules to man (Part I).
Fedak PW; Verma S; Weisel RD; Li RK
Cardiovasc Pathol; 2005; 14(1):1-11. PubMed ID: 15710285
[TBL] [Abstract][Full Text] [Related]
11. Differences in atrial versus ventricular remodeling in dogs with ventricular tachypacing-induced congestive heart failure.
Hanna N; Cardin S; Leung TK; Nattel S
Cardiovasc Res; 2004 Aug; 63(2):236-44. PubMed ID: 15249181
[TBL] [Abstract][Full Text] [Related]
12. A look between the cardiomyocytes: the extracellular matrix in heart failure.
Miner EC; Miller WL
Mayo Clin Proc; 2006 Jan; 81(1):71-6. PubMed ID: 16438481
[TBL] [Abstract][Full Text] [Related]
13. Role of apoptosis in remodeling after myocardial infarction.
Takemura G; Fujiwara H
Pharmacol Ther; 2004 Oct; 104(1):1-16. PubMed ID: 15500905
[TBL] [Abstract][Full Text] [Related]
14. Cardiac remodeling and failure: from molecules to man (Part III).
Fedak PW; Verma S; Weisel RD; Skrtic M; Li RK
Cardiovasc Pathol; 2005; 14(3):109-19. PubMed ID: 15914295
[TBL] [Abstract][Full Text] [Related]
15. Reverse remodeling following insertion of left ventricular assist devices (LVAD): a review of the morphological and molecular changes.
Wohlschlaeger J; Schmitz KJ; Schmid C; Schmid KW; Keul P; Takeda A; Weis S; Levkau B; Baba HA
Cardiovasc Res; 2005 Dec; 68(3):376-86. PubMed ID: 16024006
[TBL] [Abstract][Full Text] [Related]
16. p38 MAP kinase mediates inflammatory cytokine induction in cardiomyocytes and extracellular matrix remodeling in heart.
Li M; Georgakopoulos D; Lu G; Hester L; Kass DA; Hasday J; Wang Y
Circulation; 2005 May; 111(19):2494-502. PubMed ID: 15867183
[TBL] [Abstract][Full Text] [Related]
17. [Apoptosis of cardiomyocytes, cytokines and remodeling of myocardium against the development of chronic heart failure].
Dynnik OB; Gavrilenko TI; Zalesskiĭ VN
Lik Sprava; 2005; (5-6):3-10. PubMed ID: 16396282
[TBL] [Abstract][Full Text] [Related]
18. Mechanisms of disease: ion channel remodeling in the failing ventricle.
Nass RD; Aiba T; Tomaselli GF; Akar FG
Nat Clin Pract Cardiovasc Med; 2008 Apr; 5(4):196-207. PubMed ID: 18317475
[TBL] [Abstract][Full Text] [Related]
19. [Phenotype alterations of failing myocardium].
Takemura G; Fujiwara H
Nihon Rinsho; 2003 May; 61(5):731-8. PubMed ID: 12754995
[TBL] [Abstract][Full Text] [Related]
20. [Some aspects of metabolic remodeling of myocard during chronic heart failure].
Mamamtavrishvili N; Sanikidze T; Pavliashvili N; Kvirkvelia A; Narsia E
Georgian Med News; 2008 Jan; (154):33-6. PubMed ID: 18323590
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
